Takeda builds new Russian pharma production facility
The €75m Yaroslavl facility will initially manufacture Cardiomagnyl, Actovegin and Calcium tablets to meet the Russian demand. The 24,000m² facility will also manufacture 90 million sterile ampoules and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.